完全经肛门直肠全系膜切除术治疗直肠癌的可行性和安全性研究

注册号:

Registration number:

ChiCTR-ONC-14005103 

最近更新日期:

Date of Last Refreshed on:

2014-12-18 23:12:15 

注册时间:

Date of Registration:

2014-09-21 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

完全经肛门直肠全系膜切除术治疗直肠癌的可行性和安全性研究

Public title:

The feasibility and safety of no-scar transanal total mesorectal excision(TME) for rectal cancer

注册题目简写:

English Acronym:

研究课题的正式科学名称:

完全经肛门直肠全系膜切除术治疗直肠癌的可行性和安全性研究

Scientific title:

The feasibility and safety of no-scar transanal total mesorectal excision(TME) for rectal cancer

研究课题代号(代码):

Study subject ID:

D2014002

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

康亮 

研究负责人:

汪建平 

Applicant:

Liang Kang 

Study leader:

Jianping Wang 

申请注册联系人电话:

Applicant telephone:

+86 13602886833

研究负责人电话:

Study leader's
telephone:

+86 13808874808

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

eonkang@163.com

研究负责人电子邮件:

Study leader's E-mail:

wangjpgz@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

http://www.zs6y.com/

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

http://www.zs6y.com/

申请注册联系人通讯地址:

中山大学附属第六医院结直肠外科

研究负责人通讯地址:

中山大学附属第六医院结直肠外科

Applicant address:

Department of colorectal surgery, The Sixth Affiliated Hospital of Sun Yat-sen University

Study leader's address:

Department of colorectal surgery, The Sixth Affiliated Hospital of Sun Yat-sen University

申请注册联系人邮政编码:

Applicant postcode:

510655

研究负责人邮政编码:

Study leader's postcode:

510655

申请人所在单位:

中山大学附属第六医院结直肠外科

Applicant's institution:

Department of colorectal surgery, The Sixth Affiliated Hospital of Sun Yat-sen University

研究负责人所在单位:

Affiliation of the Leader:

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

D2014002

伦理委员会批件附件:

Approved file of Ethical Committee:

批准本研究的伦理委员会名称:

中山大学附属第六医院伦理委员会

Name of the ethic committee:

Ethics Committee of the Sixth Affiliated Hospital of Sun Yat-sen University

伦理委员会批准日期:

Date of approved by ethic committee:

2014-04-22 00:00:00

伦理委员会联系人:

Contact Name of the ethic committee:

伦理委员会联系地址:

Contact Address of the ethic committee:

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

中山大学附属第六医院结直肠外科

Primary sponsor:

Department of colorectal surgery, The Sixth Affiliated Hospital of Sun Yat-sen University

研究实施负责(组长)单位地址:

中山大学附属第六医院结直肠外科

Primary sponsor's address:

The Sixth Affiliated Hospital of Sun Yat-sen University

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

广东

市(区县):

Country:

China

Province:

Guangdong

City:

单位(医院):

中山大学附属第六医院结直肠外科

具体地址:

中山大学附属第六医院结直肠外科

Institution
hospital:

Department of colorectal surgery, The Sixth Affiliated Hospital of Sun Yat-sen University

Address:

Department of colorectal surgery, The Sixth Affiliated Hospital of Sun Yat-sen University

经费或物资来源:

Nil

Source(s) of funding:

Nil

研究疾病:

直肠癌  

Target disease:

Rectal cancer

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

连续入组 

Study design:

Sequential 

研究目的:

评估完全经肛门直肠全系膜切除术治疗直肠癌的可行性和安全性,以及其在取得腹部无疤痕的最大的美容效果的同时,是否具有疼痛轻、术后恢复快、术后排尿排便、性功能受损小,以及生活质量受影响小等优点。  

Objectives of Study:

The investigators conduct this study, looking to see if this purely transanal NOTES investigational procedure is a safe and effective approach to radically remove rectal cancer of the mid and lower rectum and see if it can reduce pain, gain faster recovery and better function and life quality when gaining the most improved cosmesis.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1、合并肠梗阻、肠穿孔、肠出血等需要急诊手术切除的病人;2、肿瘤侵犯外括约肌及肛提肌或累及邻近器官需要联合脏器切除者;3、怀孕或哺乳期妇女;4、术前肛门功能差、大便失禁者;5、严重的精神疾病;6、具有炎症性肠病病史;7、近期诊断合并其他恶性肿瘤;8、严重的肝肾功能、凝血功能障碍,合并严重的基础疾病等不能耐受手术者;9、术前有感染未控制者;10、患者或家属无法理解本研究的条件和目标

Exclusion criteria:

1. obstructing, perforated or hemorrhagic rectal cancer require for emergent surgery;
2. T4 tumor that invade the external sphincter or levator ani muscle or neighbor organs that should undergo multivisceral resection;
3. pregnant or breast-feeding women;
4. fecal incontinence;
5. mental disorder or disease;
6. history of inflammatory bowel disease;
7. other malignancies diagnosed within the previous year;
8. severe impaired renal and hepatic function, coagulopathy or other severe comorbidities that cannot tolerate surgery;
9. any evidence of active infection;
10. cannot reach written informed consent.

研究实施时间:

Study execute time:

From 2014-09-01 00:00:00 To 2017-09-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2014-09-01 00:00:00 To 2017-09-01 00:00:00

干预措施:

Interventions:

组别:

完全经肛门手术组

样本量:

40

Group:

transanal surgery

Sample size:

干预措施:

直肠癌根治性手术

干预措施代码:

Intervention:

radical surgery for rectal cancer

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

广东 

市(区县):

 

Country:

China

Province:

Guangdong

City:

单位(医院):

中山大学附属第六医院 

单位级别:

三甲医院 

Institution
hospital:

The Sixth Affiliated Hospital of Sun Yat-sen University

Level of the institution:

Tertiary A hospital

测量指标:

Outcomes:

指标中文名:

手术时间

指标类型:

主要指标

Outcome:

Operative time

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

失血量

指标类型:

主要指标

Outcome:

Estimated blood loss

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术中并发症

指标类型:

主要指标

Outcome:

intraoperative complications

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

中转腹腔镜辅助

指标类型:

主要指标

Outcome:

conver to Hybrid NOTES with assistance of conventional laparoscopic surgery

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

中转开腹

指标类型:

主要指标

Outcome:

conver to open surgery

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

手术并发症

指标类型:

主要指标

Outcome:

postoperative complication

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

肿瘤病理学指标

指标类型:

主要指标

Outcome:

pathological outcome

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

住院费用

指标类型:

主要指标

Outcome:

cost of hospitalization

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后恢复情况

指标类型:

次要指标

Outcome:

recovery outcome

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后疼痛指标

指标类型:

次要指标

Outcome:

postoperative pain evaluation

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

排尿、排便、性功能

指标类型:

次要指标

Outcome:

defecation, urinary and sexual function

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

生活质量

指标类型:

次要指标

Outcome:

Quality of life

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

3年无疾病生存

指标类型:

次要指标

Outcome:

3 year disease free survival

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

3年总生存

指标类型:

次要指标

Outcome:

3 year overall surviva

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 70 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

N/A

Randomization Procedure (please state who generates the random number sequence and by what method):

N/A

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

中山大学附属第六医院

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

The Sixth Affiliated Hospital of Sun Yat-sen University

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

中山大学附属第六医院

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

The Sixth Affiliated Hospital of Sun Yat-sen University

数据与安全监察委员会:

Data and Safety Monitoring Committee:

注册人:

Name of Registration:

 2014-08-14 00:00:00